Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of Subcutaneous Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
Conditions
Interventions
Anakinra
Placebo
Locations
8
Japan
Fukushima Medical University Hospital
Fukushima, Fukushima, Japan
Hyogo Prefectural Kobe Children's Hospital
Kobe, Hyōgo, Japan
Kobe University Hospital
Kobe, Hyōgo, Japan
Yokohama City University Hospital (Hematology and Clinical Immunology)
Yokohama, Kanagawa, Japan
Shinshu University
Matsumoto, Nagano, Japan
Tokyo Medical And Dental University Hospital
Bunkyō-Ku, Tokyo, Japan
Start Date
August 24, 2022
Primary Completion Date
December 10, 2025
Completion Date
June 24, 2026
Last Updated
March 5, 2025
NCT05715736
NCT00868751
Lead Sponsor
Swedish Orphan Biovitrum
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions